Unlock instant, AI-driven research and patent intelligence for your innovation.

Scaffold with adhesive for articular cartilage repair

A technology of articular cartilage and cartilage, applied in joint implants, joint implants, medical science, etc., can solve problems such as inability to treat large lesions, collapse, OCA disease spread to subchondral bones, etc.

Pending Publication Date: 2021-04-16
欧酷根公司
View PDF12 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, OAT is limited by donor site morbidity and inability to treat large lesion sites, and OCA carries risks of disease transmission and subchondral bone collapse

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Scaffold with adhesive for articular cartilage repair
  • Scaffold with adhesive for articular cartilage repair

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0092] The pigs are divided into at least two groups in which there is at least one control group. Each test group was applied with the barrier composition, while the control group was not applied with the barrier composition. In all groups, cartilage defects developed in the load-bearing area of ​​the medial femoral condyle of the knee joint.

[0093] In each test group, the barrier composition was applied to the subchondral bone. Multiple test panels can be generated to test various barrier compositions. In all groups, the same substrate was applied after any barrier composition. Conditions related to the application of the substrate and any top polymeric barrier over the substrate should be consistent in all test and control groups.

[0094] Testing was performed at one month and at additional time periods to determine whether the barrier composition prevented migration of subchondral components such as cells and fluid into the cartilage lesion. Such testing may include...

Embodiment 2

[0098] Scaffolds for testing in pigs were prepared as described below. A honeycomb porous collagen sponge (5 mm in diameter and 1 mm in thickness, Koken, Tokyo, Japan) was soaked in 25 μl of cold 0.3% neutralized collagen solution (Vitrogen, Cohesion Tech, Palo Alto, CA), and then incubated at 37°C 1 hour. The neutralized collagen solution solidifies to form an acellular scaffold composed of collagen gel within the sponge.

[0099] The engineered cell construct implanted with adhesive and sutures was prepared by harvesting a biopsy sample from porcine articular cartilage, mincing the biopsy sample, and dissolving it in a solution containing 100 μg / ml penicillin and 100 units / ml chain Ham's F-12 (F-12, Invitrogen) in 1.5 mg / ml collagenase (CLS 1, Worthington, Freehold, NJ) in Ham's F-12 (F-12, Invitrogen) digested on a rotator at 37°C 18 hours. Undigested tissue was removed using a cell mesh (70 μm mesh, BD Biosciences, Franklin Lakes, NJ). Isolated porcine articular chondr...

Embodiment 3

[0103] Five different engineered cell constructs were implanted into pigs and their performance compared. The 5 constructs are a) blank defect control ("blank"); b) acellular scaffold control ("scaffold") implanted with adhesive and suture; c) engineered implanted with adhesive and suture cell constructs (“cell constructs”); d) engineered cell constructs implanted with only adhesives (“glued cell constructs”); and e) implanted on subchondral bone using only sutures Engineered cell constructs ("stitched cell constructs").

[0104] Two rounds of surgery were performed in pigs. Protocols for animal studies were approved by the Animal Care and Use Regulatory Committee of Charles River Laboratories (Worcester, MA). Sixteen castrated male pigs (Micro-Yucatan, Charles River Laboratories) aged 12 to 15 months and weighing 30 to 45 kg were acclimatized for more than one week prior to the first surgery. With 0.04 mg / kg atropine sulfate (Patterson, Devens, MA), 0.55 mg / kg butorphanol ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

An injury or defect in articular cartilage is treated with a matrix implant that is applied above a barrier composition. The polymer-containing barrier composition is applied to the bottom of a cartilage lesion. The barrier composition can block migration of cells, blood, or other material from subchondral bone into the cartilage lesion.

Description

[0001] Cross References to Related Applications [0002] This application claims priority to US Provisional Application 62 / 683,358, filed June 11, 2018, the disclosure of which is incorporated herein by reference in its entirety. technical field [0003] A matrix implant is implanted in an articular cartilage lesion over a barrier composition effective to inhibit migration of cells, blood, and other materials from the subchondral region into the lesion. Background technique [0004] Articular cartilage is composed of chondrocytes embedded in a large extracellular matrix containing water molecules, collagen fibers, and proteoglycans. In active individuals and the elderly, injury to articular cartilage occurs due to acute or repetitive trauma injury or aging. Such injuries cause pain, affect mobility and can lead to disability. There are many treatments currently in use. Current surgical treatments include microfractures, irrigation, debridement, trepanation, and abrasive c...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61F2/30A61F2/00A61F2/02
CPCA61F2/30756A61F2002/30761A61F2002/30766A61F2002/30075
Inventor 詹姆斯·克罗姆
Owner 欧酷根公司